Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1997 1
1998 2
2000 1
2004 2
2005 1
2006 3
2007 3
2008 2
2009 1
2010 1
2011 1
2012 1
2014 4
2015 2
2016 3
2017 4
2018 5
2019 6
2020 3
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France.
Roussel C, Chassany O, Durand-Zaleski I, Josseran A, Alter L, Auquier P, Bourguignon S, Cachoux J, Desforges C, Fernandez J, Gaudin AF, Germe AF, Haenel E, Olivier P, Maillard N, Naïditch N, Nguyen T, Péan C, Rumeau-Pichon C, Sales JP, Schmidely N, Tuppin P, Vray M. Roussel C, et al. Among authors: bourguignon s. Therapie. 2022 Jan-Feb;77(1):89-102. doi: 10.1016/j.therap.2022.01.007. Epub 2022 Jan 13. Therapie. 2022. PMID: 35115142 French. No abstract available.
Early patient access to health technologies: Is innovation needed for early management?
Adenot I, Camus D, Épis de Fleurian AA, Tassy D; participants of Giens XXXV Round Table 'Health technologies'; Bourguignon S, Chabin N, Chambrin PY, Costagliola D, Huot L, Joly AS, Le Lous G, Martelli N, Orlikowski D, Petit V, Puc C, Roussel C, Wilquin-Bequet F. Adenot I, et al. Among authors: bourguignon s. Therapie. 2020 Jan-Feb;75(1):71-83. doi: 10.1016/j.therap.2019.11.008. Epub 2019 Dec 16. Therapie. 2020. PMID: 32044105 Review. French.
Leishmaniasis treatment--a challenge that remains: a review.
Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, Bernardino A, Bourguignon SC, Corte-Real S, Pinho RT, Rodrigues CR, Castro HC. Santos DO, et al. Among authors: bourguignon sc. Parasitol Res. 2008 Jun;103(1):1-10. doi: 10.1007/s00436-008-0943-2. Parasitol Res. 2008. PMID: 18389282 Review.
Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France.
Roussel C, Chassany O, Durand-Zaleski I, Josseran A, Alter L, Auquier P, Bourguignon S, Cachoux J, Desforges C, Fernandez J, Gaudin AF, Germe AF, Haenel E, Olivier P, Maillard N, Naïditch N, Nguyen T, Péan C, Rumeau-Pichon C, Sales JP, Schmidely N, Tuppin P, Vray M. Roussel C, et al. Among authors: bourguignon s. Therapie. 2022 Jan-Feb;77(1):103-115. doi: 10.1016/j.therap.2022.01.016. Epub 2022 Jan 31. Therapie. 2022. PMID: 35140023
Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi.
Lechuga GC, Borges JC, Calvet CM, de Araújo HP, Zuma AA, do Nascimento SB, Motta MCM, Bernardino AMR, Pereira MCS, Bourguignon SC. Lechuga GC, et al. Among authors: bourguignon sc. Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):154-164. doi: 10.1016/j.ijpddr.2016.07.001. Epub 2016 Jul 14. Int J Parasitol Drugs Drug Resist. 2016. PMID: 27490082 Free PMC article.
Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2'-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment.
Oliveira LFG, Souza-Silva F, de Castro Côrtes LM, Cysne-Finkelstein L, de Souza Pereira MC, de Oliveira Junior FO, Pinho RT, Corte Real S, Bourguignon SC, Ferreira VF, Alves CR. Oliveira LFG, et al. Among authors: bourguignon sc. Molecules. 2018 Apr 10;23(4):864. doi: 10.3390/molecules23040864. Molecules. 2018. PMID: 29642584 Free PMC article.
44 results